Trial · NCT05618587
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Fatigue Severity Scale | Change from baseline to day 21 | 7-item questionnaire assessing fatigue severity. Score range 1-49 with higher values signifying worse outcome |
| Primary | Brain Fog Severity Scale | Change from baseline to day 21 | 7-item questionnaire assessing brain fog severity. Score range 1-49 with higher values signifying worse outcome |
| Secondary | Patient Global Impression of Change (PGIC) | Day 21 | Change in symptoms on 7-point scale. Single-item scale. Score range 1-7 with higher values signifying better outcome |
| Secondary | Well-Being Scale | Change from baseline to day 21 | Sense of well-being over past week on 10-point scale. Score range 0-10 with higher values signifying better outcome. |
| Secondary | Short Form-12 Health Survey (1-week Modification) | Change from baseline to day 21 | Quality of life assessment over past week, PCS-subscale. 12-item quality of life scale. Score range 0-100 for both the Physical Component Score and the Mental Component Score with higher values signifying better outcomes. |
| Secondary | Desire to Continue Therapy | Day 21 | Single Yes/No question. Single-item scale. Score range 1-2 with higher value signifying better outcome. Reported as % of respondents recording "yes". |
| Secondary | Generalized Anxiety Disorder-2 Scale | Change from baseline to day 21 | 2-item questionnaire assessing anxiety frequency over the past week. 2-item scale. Score range 0-6 with higher values signifying worse outcome |
| Secondary | Headache and Body Pain Bother Scale | Change from baseline to day 21 | 2-item questionnaire assessing frequency of headaches and body pain over the past week, Headache score. 2-item scale. Score range 2-10 with higher values signifying worse outcome |
| Secondary | Insomnia Severity Index | Change from baseline to day 21 | 7-item questionnaire assessing insomnia severity over the past week. 7-item scale. Score range 0-28 with higher values signifying worse outcome. |
| Secondary | Sense of Smell and Taste Change Scale | Day 21 | Subjective change from baseline on a 7-point scale (score range: 1-7) with higher scores indicating better outcomes. Scores of 1 and 7 indicate sense of smell and taste were "very much worse" or "very much improved", respectively, since the start of study treatment. |
| Secondary | Digit Symbol Substitution Test | Change from baseline to day 21 | Validated cognitive test. Score range 0-100 with higher scores indicating a better outcome. |
| Secondary | Delayed Recall Test | Change from baseline to day 21 | Validated cognitive test. Score range 0-5 with higher scores indicating better outcomes. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05618587/registered